BeatProfiler, a novel suite of cardiac analysis tools powered by machine learning, marks a groundbreaking advancement in cardiac research. Developed by Columbia University researchers, BeatProfiler automates heart cell analysis, facilitating precise measurements of contractility…
Continue Reading
Revolutionizing healthcare with cutting-edge AI solutions, NVIDIA introduces 25 groundbreaking genAI microservices. These cloud-agnostic tools empower developers to seamlessly integrate AI into diverse healthcare applications, fostering advancements in genomics, imaging, drug discovery, and beyond….
Continue Reading
The following is a guest article by Ben Cushing, Chief Architect of Health and Life Sciences at Red Hat
Artificial intelligence (AI) is showing up in more healthcare contexts, from drug discovery to diagnostic imaging…
What You Should Know:
NVIDIA today launched more than two dozen new microservices that allow healthcare enterprises worldwide to take advantage of the latest advances in generative AI from anywhere and on any cloud.The new suite…
Continue Reading
Israel-based AION Labs, an AI-enabled drug discovery partnership between global pharma and tech companies, announced the launch of a new startup company CombineAble.AI, which will speed up the development of therapeutics by addressing challenges…
Continue Reading
What You Should Know:
– Absci Corporation (Nasdaq: ABSI), a company utilizing generative AI for drug discovery, announced today an initial public offering (IPO) of $75 million in common stock.
– This IPO aims to support…
Continue Reading
Publicly listed Daewoong Pharmaceutical has recently unveiled its AI-driven drug development system, powered by a database of hundreds of millions of pre-processed compounds. WHAT IT’S ABOUT
Over the past two years, researchers of the Seoul-based pharma…
Get to the Core of AI Currently, there are successful AI use cases in automated documentation, medical imaging, clinical decision support, patient monitoring, patient classification, intelligent search and retrieval, data analysis and insights, drug…
Continue Reading
What You Should Know: InSilico Medicine, a clinical-stage company utilizing generative artificial intelligence (AI) for drug discovery, reveals the development of an orally bioavailable preclinical candidate compound. This compound targets KIF18A and aims to treat…
Continue Reading
What You Should Know:
– H1, the go-to resource for healthcare professionals, clinical trial information, and life sciences research, announced the launch of its conversational AI tool GenosAI Pro.
– The conversational AI tool empowers pharmaceutical…
Continue Reading
